Company news

Anixa Biosciences, Inc. news in 2021

Anixa Biosciences, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study

October 25, 2021

Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology

October 5, 2021

Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy

September 30, 2021

Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer

September 6, 2021

Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy

August 29, 2021

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology

August 17, 2021

Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic

May 25, 2021

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

March 21, 2021

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

March 11, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

March 3, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

February 15, 2021

Decks in 2021